OUR TECHNOLOGY IS UNMATCHED. SO IS OUR LEADERSHIP.  

Stephen J. Fanning was appointed President and Chief Executive Officer of Solta Medical, Inc. (formerly Thermage, Inc.), a leader in non-invasive tissue tightening in the aesthetic industry, on January 15, 2005. He was elected Chairman of the Board of Directors effective as of July 31, 2006. Under his leadership, the Company went public in November 2006, raising $42 million. Also, in January 2009, he led the successful integration of the acquisition of Reliant Technologies, Inc., which combined the industry's two leading brands, Thermage® and Fraxel®, under a new corporate name of Solta Medical Inc., forming a global leader in aesthetic energy devices. Mr. Fanning has an extensive background in the healthcare, consumer pharmaceuticals and consumer package goods industries.

Mr. Fanning joined Thermage, Inc. from Ocular Sciences, Inc., a $350 million global public company, which developed, manufactured and marketed disposable contact lenses. Mr. Fanning had been President and Chief Executive Officer of the Company and a member of the Board of Directors since August 13, 2001. Under his leadership, Ocular Sciences implemented a next-generation manufacturing process significantly driving down the cost of goods sold, achieved significant increases in global market share and attained more than $300 million in annual sales. In January 2005, Ocular Sciences was successfully acquired by CooperVision for $1.3 billion.

Mr. Fanning joined Ocular Sciences from Johnson & Johnson (J&J), one of the world's largest manufacturers of healthcare products, where he served in various senior executive positions of escalating responsibility for 25 years. His most recent position was President, Worldwide, of J&J's McNeil pecialty Products division. Prior to that, he served as President of Johnson & Johnson Medical, a medical device company. Mr. Fanning has also served as Managing Director of J&J Austria/Switzerland, and Vice President, Sales, of J&J's McNeil Consumer Products Division.

Mr. Fanning holds a Bachelor of Science degree from Philadelphia University.

Bill Brodie joined Thermage in February of 2006 as Director of Sales, Eastern US. Mr. Brodie was promoted to Vice President of Global Sales in January of 2009. He brings more than 17 years of sales management experience and business development in both the medical and dental markets. Most recently, he served as Vice President of Sales and Field Operations with Benco Dental Company, a leader in dental office equipment sales, office design and supply management. His responsibilities for this $300 million, privately-held company included leading a sales force of over 600 field personnel, as well as inside sales, international sales, and practice development consulting. From 1998 to 2002 he held various sales management positions with Benco. Prior to 1998 Mr. Brodie was the founder, president and owner of Quality Central Dental a dental sales company based in Orlando, FL until the 1998 merger with Benco. He holds a Master of Science in Management from Georgia Institute of Technology, and a Bachelor of Science from Rollins College.

Clint Carnell joined Thermage in September 2005 as Vice President of Domestic Sales. Mr. Carnell was appointed Chief Operating Officer in January 2008. Mr. Carnell brings 15 years of experience to Thermage in medical device sales, sales management and business development with both public and private companies. Most recently, he served as Vice President of US Surgical Sales with Bausch and Lomb where he oversaw the turnaround of a $215 million division of B&L, including responsibility for the cataract, refractive and vitreoretinal sales and support teams. Prior to 2000, Mr. Carnell held the role of Director of Corporate Development with Gambro Healthcare where he was responsible for the development of dialysis clinics and physician partnerships with nephrologists. Prior to Gambro, Mr. Carnell held various sales and sales management positions with companies such as Johnson & Johnson, Versyss Medical and in the financial software industry. Mr. Carnell was the founder and a board member of privately held Charleston Renal Care, recently sold to DaVita, Inc. Mr. Carnell holds a Bachelor of Arts from Duke University.

Len DeBenedictis has more than 30 years of experience in lasers, laser scanners, medical systems and senior management within the laser industry, and he has been the driving force behind the breakthrough technology in the Fraxel® family of lasers. Beginning in 2001, he has provided leadership to the company as President, Chief Technology Officer and CEO. In his present role, Mr. DeBenedictis directs the development of Reliant's new technology, products and applications. Before joining Reliant, Mr. DeBenedictis spent 11 years with Coherent Inc. in a variety of positions, ultimately becoming General Manager of the Medical Group. At Coherent, Mr. DeBenedictis turned a poorly performing division into a profitable one with annual sales exceeding $100 million. During that period, Coherent Medical introduced the UltraPulse CO2 laser, the most rapidly adopted aesthetic laser product until the release of the Fraxel laser. Many of Coherent's leading engineers and executives have joined Mr. DeBenedictis at Reliant Technologies, a testament to their belief in his vision and leadership abilities. Prior to Coherent, Mr. DeBenedictis was the Engineering Manager for the Construction Systems Division of Spectra Physics, Inc.; Director of Operations and Engineering at ARCO Ventures; and Manager of Laser Scanning Technology for Xerox. While leading the Laser Scanning Technology Center for Xerox, Mr. DeBenedictis developed the insights that have fueled the patented technology underlying the Fraxel laser.

Dan Ferrari joined Thermage in November 2004 and brings more than 20 years of financial management experience with both public and private companies including over 11 years in the medical device industry. From 2001 to 2004, Mr. Ferrari served as Vice President, Corporate Controller of Critical Path, Inc., a $70 million revenue publicly held enterprise software and hosted messaging company, where he rebuilt the financial organization, established strong financial controls, and managed restructuring of the company. From 1999 to 2001, Mr. Ferrari was a financial consultant for a number of private companies, advising executive management regarding business model optimization, mergers and acquisitions, funding strategy, the IPO process and other financial matters. Prior to consulting, Mr. Ferrari served as Vice President, Finance of ReSound, Inc. a publicly held hearing device company, and was with the company from 1994 through 1999. During his tenure at ReSound, Mr. Ferrari was a major contributor on several acquisitions, establishment of an offshore manufacturing facility, and a number of securities offerings as revenues grew from $35 million to over $125 million prior to sale of the company to GN Great Nordic. Mr. Ferrari holds a BS in Commerce and MBA from Santa Clara University.

Jack Glenn joined Thermage in January 2008 as Chief Financial Officer, bringing with him almost 25 years of financial leadership experience with both private and publicly traded companies. He joins the Company from Cholestech, Inc., a publicly traded company providing diagnostic tools for the monitoring and assessment of heart disease, where he held the role of Chief Financial Officer and Vice President of Finance for three years before assisting in its strategic acquisition by Inverness Medical Innovations. Prior to Cholestech, Mr. Glenn held the role of Chief Financial Officer and Vice President of Finance for Invivo Corporation for 14 years. Invivo Corporation, a publicly traded medical device manufacturer, was sold to Intermagnetics in January of 2004. During Mr. Glenn's tenure at Invivo Corporation, he played a key role in the identification, negotiation and structuring of four successful acquisitions, two secondary public equity offerings and two divestitures of non-strategic businesses. Mr. Glenn holds a BS in business administration from the University of Nevada and an MBA from Santa Clara University.

Doug Heigel joined Thermage in May of 2002 as Senior Director of Operations and in July of 2003 he was promoted to the position of Vice President of Operations. He has more than 20 years of management experience involving engineering, manufacturing, supply chain management and product service related to scientific instrumentation, capital equipment and related consumables. From 1995 until 2002, Mr. Heigel was Vice President of Manufacturing for Argonaut Technologies, a manufacturer of automated synthesis equipment and chemistry consumables utilized in pharmaceutical and biotech drug discovery research. Mr. Heigel developed Argonaut's instrument manufacturing capability and introduced several successful instrument product lines that propelled Argonaut through a successful IPO in 2000. From 1988 to 1995 Mr. Heigel held Engineering and Operations Management positions at Microsensor Technology, a manufacturer of innovative, portable gas analyzers that was acquired by Agilent Technologies. Mr. Heigel earned his BS in Mechanical Engineering from Oregon State University.

Jeff Nardoci joined Solta Medical in September 2009 as Vice President of Global Marketing. Jeff brings more than 19 years of experience in marketing and strategic consumer development in both the medical and consumer goods markets. Most recently, Jeff served as Vice President of Commercial Operations, U.S. Vision Care with Bausch & Lomb, where he was responsible for a $530 million portfolio of lens, lens care and OTC pharmaceuticals. Mr. Nardoci spent 11 years at Bausch & Lomb in increasingly responsible positions. Prior to Bausch & Lomb, he was an executive consultant at Meridian Euro RSCG, a sales and marketing consulting group. His experience also includes seven years at Nabisco in the specialty foods marketing organization. Mr. Nardoci has a B.A. in Economics from Fairleigh Dickinson University.